$205.83 3.5%
RMD Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Resmed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.


Resmed
Price $205.83
Target Price Sign up
Volume 2,710,000
Market Cap $30.8B
Year Range $133.57 - $220.63
Dividend Yield 0.9%
PE Ratio 32.28
Revenue per Employee $555,015
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '241.21B742M693M300M382M2.130
Q4 '231.17B811M647M209M283M1.880
Q3 '231.11B734M600M219M298M1.640
Q2 '231.04B741M617M230M284M1.600
Q1 '231.12B736M618M233M309M1.680

Insider Transactions View All

Sandercock Brett filed to sell 91,056 shares at $209.8.
June 11 '24
Farrell Michael J. filed to sell 440,799 shares at $211.7.
June 10 '24
De Witte Jan filed to sell 7,519 shares at $218.3.
May 17 '24
De Witte Jan filed to sell 7,519 shares at $218.3.
May 22 '24
Sandercock Brett filed to sell 92,056 shares at $211.4.
May 10 '24

Congress Trading View All

Politician Filing Date Type Size
Thomas Tuberville
Republican
Nov 16, 23 Buy $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Resmed?

The Market Cap of Resmed is $30.8B.

What is Resmed's PE Ratio?

As of today, Resmed's PE (Price to Earnings) ratio is 32.28.

How Many People Work at Resmed?

As of our latest update, Resmed employed approximately 8,160 people worldwide. However, it's important to note that Resmed's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Resmed's revenue per employee?

$555,015. To calculate Resmed's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Resmed?

Currently, the price of one share of Resmed stock is $205.83.

How can I analyze the RMD stock price chart for investment decisions?

The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.

Does RMD offer dividends to its shareholders?

Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.9%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Resmed?

Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.